138 related articles for article (PubMed ID: 27070919)
21. CD154-CD40 interactions in the control of murine B cell hematopoiesis.
Carlring J; Altaher HM; Clark S; Chen X; Latimer SL; Jenner T; Buckle AM; Heath AW
J Leukoc Biol; 2011 May; 89(5):697-706. PubMed ID: 21330346
[TBL] [Abstract][Full Text] [Related]
22. Increased CD40 expression on articular chondrocytes from patients with rheumatoid arthritis: contribution to production of cytokines and matrix metalloproteinases.
Gotoh H; Kawaguchi Y; Harigai M; Hara M; Saito S; Yamaguchi T; Shimada K; Kawamoto M; Tomatsu T; Kamatani N
J Rheumatol; 2004 Aug; 31(8):1506-12. PubMed ID: 15290728
[TBL] [Abstract][Full Text] [Related]
23. Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity.
Amirkhosravi A; Amaya M; Desai H; Francis JL
Blood Coagul Fibrinolysis; 2002 Sep; 13(6):505-12. PubMed ID: 12192302
[TBL] [Abstract][Full Text] [Related]
24. Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis.
Ruth AJ; Kitching AR; Semple TJ; Tipping PG; Holdsworth SR
J Am Soc Nephrol; 2003 Nov; 14(11):2813-22. PubMed ID: 14569091
[TBL] [Abstract][Full Text] [Related]
25. Platelet-associated CD40/CD154 mediates remote tissue damage after mesenteric ischemia/reperfusion injury.
Lapchak PH; Ioannou A; Kannan L; Rani P; Dalle Lucca JJ; Tsokos GC
PLoS One; 2012; 7(2):e32260. PubMed ID: 22384195
[TBL] [Abstract][Full Text] [Related]
26. Platelet CD40 contributes to enhanced monocyte chemoattractant protein 1 levels in patients with resistant hypertension.
Stumpf C; Raaz D; Klinghammer L; Schneider M; Schmieder RE; Garlichs CD; Achenbach S
Eur J Clin Invest; 2016 Jun; 46(6):564-71. PubMed ID: 27090943
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia.
Garlichs CD; John S; Schmeisser A; Eskafi S; Stumpf C; Karl M; Goppelt-Struebe M; Schmieder R; Daniel WG
Circulation; 2001 Nov; 104(20):2395-400. PubMed ID: 11705814
[TBL] [Abstract][Full Text] [Related]
28. CD40 ligand (CD154) takes part in regulation of the transition to mononuclear cell dominance during peritonitis.
Mazar J; Agur T; Rogachev B; Ziv NY; Zlotnik M; Chaimovitz C; Douvdevani A
Kidney Int; 2005 Apr; 67(4):1340-9. PubMed ID: 15780086
[TBL] [Abstract][Full Text] [Related]
29. Soluble CD40 ligand induces human coronary artery smooth muscle cells proliferation and migration.
Chai H; Aghaie K; Zhou W
Surgery; 2009 Jul; 146(1):5-11. PubMed ID: 19541004
[TBL] [Abstract][Full Text] [Related]
30. CD154 Induces Interleukin-6 Secretion by Kidney Tubular Epithelial Cells under Hypoxic Conditions: Inhibition by Chloroquine.
Dewitte A; Villeneuve J; Lepreux S; Bouchecareilh M; Gauthereau X; Rigothier C; Combe C; Ouattara A; Ripoche J
Mediators Inflamm; 2020; 2020():6357046. PubMed ID: 32089648
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand.
Menchén L; Marín-Jiménez I; Arias-Salgado EG; Fontela T; Hernández-Sampelayo P; Rodríguez MC; Butta NV
Gut; 2009 Jul; 58(7):920-8. PubMed ID: 19039088
[TBL] [Abstract][Full Text] [Related]
32. Fenofibrate inhibits tumor necrosis factor-alpha-induced expression of CD40 and matrix metalloproteinase in human vascular endothelial cells.
Lin R; Liu JT; Gan WJ; Wang WR; Han CJ; Liu Y; Fang ZY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1383-7. PubMed ID: 17062332
[TBL] [Abstract][Full Text] [Related]
33. CD40-TRAF Signaling Upregulates CX3CL1 and TNF-α in Human Aortic Endothelial Cells but Not in Retinal Endothelial Cells.
Greene JA; Portillo JA; Lopez Corcino Y; Subauste CS
PLoS One; 2015; 10(12):e0144133. PubMed ID: 26710229
[TBL] [Abstract][Full Text] [Related]
34. CD40 ligand increases expression of its receptor CD40 in human coronary artery endothelial cells.
Chai H; Yan S; Wang H; Zhang R; Lin PH; Yao Q; Chen C
Surgery; 2006 Aug; 140(2):236-42. PubMed ID: 16904975
[TBL] [Abstract][Full Text] [Related]
35. Role of nephrin in podocyte injury induced by angiotension II.
Yu S
J Recept Signal Transduct Res; 2016; 36(1):1-5. PubMed ID: 25264225
[TBL] [Abstract][Full Text] [Related]
36. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
[TBL] [Abstract][Full Text] [Related]
37. Platelet-associated CD154 in immune thrombocytopenic purpura.
Solanilla A; Pasquet JM; Viallard JF; Contin C; Grosset C; Déchanet-Merville J; Dupouy M; Landry M; Belloc F; Nurden P; Blanco P; Moreau JF; Pellegrin JL; Nurden AT; Ripoche J
Blood; 2005 Jan; 105(1):215-8. PubMed ID: 15191945
[TBL] [Abstract][Full Text] [Related]
38. Ligation of CD40 onvascular smooth muscle cells mediates loss of interstitial collagen via matrix metalloproteinase activity.
Horton DB; Libby P; Schonbeck U
Ann N Y Acad Sci; 2001 Dec; 947():329-36. PubMed ID: 11795284
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenofibrate on it in human vascular endothelial cells.
Lin R; Liu J; Gan W; Yang G
Biol Pharm Bull; 2004 Oct; 27(10):1537-43. PubMed ID: 15467191
[TBL] [Abstract][Full Text] [Related]
40. [Platelet-associated CD154: a new interface in haemostasis and in the inflammatory reaction].
Delmas Y; Viallard JF; Villeneuve J; Grosset C; Pasquet JM; Déchanet-Merville J; Nurden P; Pellegrin JL; Rosenbaum J; Combe C; Nurden AT; Ripoche J
Med Sci (Paris); 2005 Oct; 21(10):825-31. PubMed ID: 16197899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
